Cybin to Participate at the 2025 Milken Institute Future of Health Summit
– Chief Medical Officer Amir Inamdar to participate in a panel on November 5, 2025 – TORONTO — Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizin
(Financial Post, 2025-11-03T12:30:35Z)